Results 251 to 260 of about 40,867 (262)

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Lancet, The, 2012
Fred Saad, Robert Coleman, Frcp, Neal D Shore, Facs   +2 more
exaly  

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

Nature Reviews Drug Discovery, 2012
John K Sullivan
exaly  

Denosumab

Nature Reviews Drug Discovery, 2010
René Rizzoli, Peter Kirkpatrick
exaly  

Denosumab in castration-resistant prostate cancer

Lancet, The, 2012
Athanassios Kyrgidis
exaly  

Denosumab in castration-resistant prostate cancer – Authors' reply

Lancet, The, 2012
Fred Saad
exaly  

Denosumab

Reactions Weekly, 2017
openaire   +2 more sources

Denosumab—a new option for solid tumors metastatic to bone

Nature Reviews Clinical Oncology, 2011
Philip J Saylor
exaly  

Denosumab in Postmenopausal Women with Low Bone Mineral Density

New England Journal of Medicine, 2006
E Michael Lewiecki
exaly  

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

Lancet Oncology, The, 2010
David Thomas, Winnie Y Sohn
exaly  

Denosumab in patients with cancer—a surgical strike against the osteoclast

Nature Reviews Clinical Oncology, 2012
exaly